Literature DB >> 7487609

Stickler syndrome. A mutation in the nonhelical 3' end of type II procollagen gene.

N N Ahmad1, J Dimascio, R G Knowlton, W S Tasman.   

Abstract

BACKGROUND: All of the mutations in the type II procollagen (COL2A1) gene that have been identified in families affected with Stickler syndrome have been located primarily in the triple helical region of the gene. We report what we believe is the first premature stop codon in the globular C-propeptide region encoded by the COL2A1 gene, in a family affected with Stickler syndrome.
DESIGN: Genomic DNA from affected and unaffected family members of this three-generation family was amplified using the polymerase chain reaction. The polymerase chain reaction products were directly sequenced for DNA analysis.
RESULTS: Direct sequencing showed a single base deletion in exon 50, resulting in a premature stop codon in exon 51 in the globular C-propeptide of COL2A1 gene in all affected members.
CONCLUSIONS: These results implicate premature stop codons as a common cause of Stickler syndrome. The location of this premature stop codon in the far end of the nonhelical 3' end of the gene indicates that a truncated C-propeptide of at least 84 amino acid residues is inadequate for the functional gene product.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487609     DOI: 10.1001/archopht.1995.01100110114034

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  16 in total

1.  The heterozygous disproportionate micromelia (dmm) mouse: morphological changes in fetal cartilage precede postnatal dwarfism and compared with lethal homozygotes can explain the mild phenotype.

Authors:  Robert E Seegmiller; Brandon D Bomsta; Laura C Bridgewater; Cindy M Niederhauser; Carolina Montaño; Sterling Sudweeks; David R Eyre; Russell J Fernandes
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

Review 2.  Ophthalmic eponyms from the Mayo Clinic.

Authors:  G B Bartley
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

3.  PCR assay confirms diagnosis in syndrome with variably expressed phenotype: mutation detection in Stickler syndrome.

Authors:  N N Ahmad; D M McDonald-McGinn; P Dixon; E H Zackai; W S Tasman
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

4.  Dwarfism and age-associated spinal degeneration of heterozygote cmd mice defective in aggrecan.

Authors:  H Watanabe; K Nakata; K Kimata; I Nakanishi; Y Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 5.  Clinical and Molecular genetics of Stickler syndrome.

Authors:  M P Snead; J R Yates
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

6.  Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations.

Authors:  J Körkkö; L Ala-Kokko; A De Paepe; L Nuytinck; J Earley; D J Prockop
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

Review 7.  Human hereditary hearing impairment: mouse models can help to solve the puzzle.

Authors:  Karen Vrijens; Lut Van Laer; Guy Van Camp
Journal:  Hum Genet       Date:  2008-09-11       Impact factor: 4.132

8.  A novel retinoic acid-response element requires an enhancer element mediator for transcriptional activation.

Authors:  Laura R Harris; Olli-Pekka Kamarainen; Minna Sevakivi; Gwen C Miller; James W Clarke; Jennifer L Potter; Laura C Bridgewater
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 9.  MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness.

Authors:  Lilach M Friedman; Karen B Avraham
Journal:  Mamm Genome       Date:  2009-10-30       Impact factor: 2.957

10.  Osteoarthritis in temporomandibular joint of Col2a1 mutant mice.

Authors:  M L Ricks; J T Farrell; D J Falk; D W Holt; M Rees; J Carr; T Williams; B A Nichols; L C Bridgewater; P R Reynolds; D L Kooyman; R E Seegmiller
Journal:  Arch Oral Biol       Date:  2013-03-19       Impact factor: 2.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.